Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer

Ivermectin is a widely used antiparasitic drug and shows promising anticancer activity in various cancer types. Although multiple signaling pathways modulated by ivermectin have been identified in tumor cells, few studies have focused on the exact target of ivermectin. Herein, we report the pharmaco...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Shidong, Wu, Zeyu, Luo, Mayao, Zhang, Yifan, Zhang, Jianqiang, Pascal, Laura E., Wang, Zhou, Wei, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436997/
https://www.ncbi.nlm.nih.gov/pubmed/36050295
http://dx.doi.org/10.1038/s41419-022-05182-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436997/
https://www.ncbi.nlm.nih.gov/pubmed/36050295
http://dx.doi.org/10.1038/s41419-022-05182-0

Ejemplares similares